Eventide Asset Management’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $53.4M | Sell |
|
|||||
|
2020
Q1 | $55.5M | Buy |
|
|||||
|
2019
Q4 | $103M | Hold |
|
|||||
|
2019
Q3 | $64.6M | Buy |
|
|||||
|
2019
Q2 | $57.8M | Buy |
|
|||||
|
2019
Q1 | $43.9M | Buy |
|
|||||
|
2018
Q4 | $41.6M | Hold |
|
|||||
|
2018
Q3 | $47.4M | Buy |
|
|||||
|
2018
Q2 | $43.6M | Buy |
|
|||||
|
2018
Q1 | $49.8M | Buy |
|
|||||
|
2017
Q4 | $46.4M | Buy |
|
|||||
|
2017
Q3 | $25.5M | Hold |
|
|||||
|
2017
Q2 | $21.2M | Buy |
|
|||||
|
2017
Q1 | $6.74M | Buy |
|